Yohannes Ghebremariam

Publications

• FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats. Ghebremariam YT, Yamada K, Lee JC, Johnson CL, Atzler D, Anderssohn M, Agrawal R, Higgins JP, Patterson AJ, Böger RH, Cooke JP. PLoS One. 2013; 8 (4): e60653
• Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells. White MP, Rufaihah AJ, Liu L, Ghebremariam YT, Ivey KN, Cooke JP, Srivastava D. Stem Cells. 2013; 31 (1): 92-103
• Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening. Ghebremariam YT, Erlanson DA, Yamada K, Cooke JP. J Biomol Screen. 2012; 17 (5): 651-61
• DDAH says NO to ADMA. Cooke JP, Ghebremariam YT. Arterioscler Thromb Vasc Biol. 2011; 31 (7): 1462-4
• Dietary nitrate, nitric oxide, and restenosis. Cooke JP, Ghebremariam YT. J Clin Invest. 2011; 121 (4): 1258-60
• Vaccinia virus complement control protein (VCP) improves kidney structure and function following ischemia/reperfusion injury in rats. Ghebremariam YT, Engelbrecht G, Tyler M, Lotz Z, Govender D, Kotwal GJ, Kahn D. J Surg Res. 2010; 159 (2): 747-54
• Cell-free production of transducible transcription factors for nuclear reprogramming. Yang WC, Patel KG, Lee J, Ghebremariam YT, Wong HE, Cooke JP, Swartz JR. Biotechnol Bioeng. 2009; 104 (6): 1047-58
• Endothelial nicotinic acetylcholine receptors and angiogenesis. Cooke JP, Ghebremariam YT. Trends Cardiovasc Med. 2008; 18 (7): 247-53
• Candidate inhibitors of porcine complement. Thorgersen EB, Ghebremariam YT, Thurman JM, Fung M, Nielsen EW, Holers VM, Kotwal GJ, Mollnes TE. Mol Immunol. 2007; 44 (8): 1827-34
• Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral. Kotwal GJ, Kaczmarek JN, Leivers S, Ghebremariam YT, Kulkarni AP, Bauer G, De Beer C, Preiser W, Mohamed AR. Ann N Y Acad Sci. 2005: 1056 293-302
• Curcumin inhibits the classical and the alternate pathways of complement activation. Kulkarni AP, Ghebremariam YT, Kotwal GJ. Ann N Y Acad Sci. 2005: 1056 100-12
• Human Xenotransplantaton: An Immunological and Ethical Challenge Yohannes T Ghebremariam, Scott A Smith, Jamie B Anderson, Del Kahn, Girish J Kotwal. New Research on Immunology. 2005: 127-145
• Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways. Ghebremariam YT, Odunuga OO, Janse K, Kotwal GJ. Ann N Y Acad Sci. 2005: 1056 113-22
• Intervention strategies and agents mediating the prevention of xenorejection. Ghebremariam YT, Smith SA, Anderson JB, Kahn D, Kotwal GJ. Ann N Y Acad Sci. 2005: 1056 123-43